These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21162607)

  • 1. Clinical experience with bemiparin.
    Abad Rico JI; Lozano Sánchez FS; Rocha E
    Drugs; 2010 Dec; 70 Suppl 2():25-33. PubMed ID: 21162607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis.
    Chapman TM; Goa KL
    Drugs; 2003; 63(21):2357-77. PubMed ID: 14524738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of bemiparin sodium versus unfractionated heparin and oral anticoagulants in the acute and long-term treatment of deep vein thrombosis.
    Gómez-Outes A; Rocha E; Martínez-González J; Kakkar VV
    Pharmacoeconomics; 2006; 24(1):81-92. PubMed ID: 16445305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of bemiparin sodium--a new second-generation low molecular weight heparin and its applications in venous thromboembolism.
    Planès A
    Expert Opin Pharmacother; 2003 Sep; 4(9):1551-61. PubMed ID: 12943485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoeconomic analysis of bemiparin and enoxaparin as prophylaxis for venous thromboembolism in total knee replacement surgery.
    Honorato J; Gómez-Outes A; Navarro-Quilis A; Martínez-González J; Rocha E; Planès A
    Pharmacoeconomics; 2004; 22(13):885-94. PubMed ID: 15329033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentasaccharides for the prevention of venous thromboembolism.
    Dong K; Song Y; Li X; Ding J; Gao Z; Lu D; Zhu Y
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005134. PubMed ID: 27797404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparin, bemiparin, in the outpatient treatment and secondary prophylaxis of venous thromboembolism in standard clinical practice: the ESFERA Study.
    Santamaría A; Juárez S; Reche A; Gómez-Outes A; Martínez-González J; Fontcuberta J;
    Int J Clin Pract; 2006 May; 60(5):518-25. PubMed ID: 16700847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
    Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
    Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enoxaparin. A pharmacoeconomic appraisal of its use in thromboembolic prophylaxis after total hip arthroplasty.
    Dunn CJ; Goa KL
    Pharmacoeconomics; 1996 Aug; 10(2):179-90. PubMed ID: 10163420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
    Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
    Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bemiparin for thromboprophylaxis after benign gynecologic surgery: a randomized clinical trial.
    Alalaf SK; Jawad AK; Jawad RK; Ali MS; Al Tawil NG
    J Thromb Haemost; 2015 Dec; 13(12):2161-7. PubMed ID: 26448633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
    Robertson L; Strachan J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bemiparin in oncology.
    Monreal Bosch M; Vignoli A; Lecumberri Villamediana R; Prandoni P
    Drugs; 2010 Dec; 70 Suppl 2():35-42. PubMed ID: 21162608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ximelagatran/Melagatran: a review of its use in the prevention of venous thromboembolism in orthopaedic surgery.
    Evans HC; Perry CM; Faulds D
    Drugs; 2004; 64(6):649-78. PubMed ID: 15018597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enoxaparin may be associated with lower rates of mortality than unfractionated heparin in neurocritical and surgical patients.
    Samuel S; To C; Ling Y; Zhang K; Jiang X; Bernstam EV
    J Thromb Thrombolysis; 2023 Apr; 55(3):439-448. PubMed ID: 36624202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG
    Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bemiparin versus enoxaparin as thromboprophylaxis following vaginal and abdominal deliveries: a prospective clinical trial.
    Alalaf SK; Jawad RK; Muhammad PR; Ali MS; Al Tawil NG
    BMC Pregnancy Childbirth; 2015 Mar; 15():72. PubMed ID: 25884460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.